Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray.

To obtain a genomic portrait of heart failure derived from end-stage dilated cardiomyopathy (DCM), we explored expression analysis using the CardioChip, a nonredundant 10,848-element human cardiovascular-based expressed sequence tag glass slide cDNA microarray constructed in-house. RNA was extracted from the left ventricular free wall of seven patients undergoing transplantation, and five nonfailing heart samples. Cy3- and Cy5-labeled (and reverse dye-labeled) cDNA probes were synthesized from individual diseased or nonfailing adult heart RNA, and hybridized to the array. More than 100 transcripts were consistently differentially expressed in DCM >1.5-fold (versus pooled nonfailing heart, P < 0.05). Atrial natriuretic peptide was found to be up-regulated in DCM (19-fold compared to nonfailing, P < 0.05), as well as numerous sarcomeric and cytoskeletal proteins (eg, cardiac troponin, tropomyosin), stress response proteins (eg, HSP 40, HSP 70), and transcription/translation regulators (eg, CCAAT box binding factor, eIF-1AY). Down-regulation was most prominently observed with cell-signaling channels and mediators, particularly those involved in Ca(2+) pathways (Ca(2+)/calmodulin-dependent kinase, inositol 1,4,5-trisphosphate receptor, SERCA). Most intriguing was the co-expression of several novel, cardiac-enriched expressed sequence tags. Quantitative real-time reverse transcriptase-polymerase chain reaction of a selection of these clones verified expression. Our study provides a preliminary molecular profile of DCM using the largest human heart-specific cDNA microarray to date.

[1]  H. Watkins,et al.  Altered Regulatory Properties of Human Cardiac Troponin I Mutants That Cause Hypertrophic Cardiomyopathy* , 2000, The Journal of Biological Chemistry.

[2]  Construction of a human heart cDNA library and identification of cardiovascular based genes (CVBest). , 1997 .

[3]  G. Francis.  Changing the remodeling process in heart failure: basic mechanisms and laboratory results. , 1998, Current opinion in cardiology.

[4]  T. Toyofuku,et al.  Molecular Regulation of Phospholamban Function and Gene Expressiona , 1998, Annals of the New York Academy of Sciences.

[5]  K P Fung,et al.  A genome-based resource for molecular cardiovascular medicine: toward a compendium of cardiovascular genes. , 1997, Circulation.

[6]  M. Matsuzaki,et al.  Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy , 1997, Nature Genetics.

[7]  C. Erneux,et al.  Cloning and expression of a cDNA encoding human inositol 1,4,5-trisphosphate 3-kinase C. , 2000, The Biochemical journal.

[8]  S. Tsui,et al.  A catalogue of genes in the cardiovascular system as identified by expressed sequence tags. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  F. Spinale,et al.  Controlling myocardial matrix remodeling: implications for heart failure. , 1999, Cardiology in review.

[10]  Minoru Hongo,et al.  MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart Failure , 1997, Cell.

[11]  M Hiroe,et al.  Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. , 1999, Biochemical and biophysical research communications.

[12]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.

[13]  K. Chien.  Genomic circuits and the integrative biology of cardiac diseases , 2000, Nature.

[14]  L. Hawthorn,et al.  Decreased SLIM1 Expression and Increased Gelsolin Expression in Failing Human Hearts Measured by High-Density Oligonucleotide Arrays , 2000, Circulation.

[15]  H. Watkins,et al.  Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein. , 2000, Circulation research.

[16]  J. Towbin,et al.  Genetic abnormalities responsible for dilated cardiomyopathy , 2000, Current cardiology reports.

[17]  L. Leinwand,et al.  Hypertrophy, pathology, and molecular markers of cardiac pathogenesis. , 1998, Circulation research.

[18]  C. Seidman,et al.  Many roads lead to a broken heart: the genetics of dilated cardiomyopathy. , 2001, American journal of human genetics.

[19]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[20]  V. Dzau,et al.  Genomics and the pathophysiology of heart failure , 2001, Current cardiology reports.

[21]  E. Olson,et al.  Cardiac hypertrophy: sorting out the circuitry. , 1999, Current opinion in genetics & development.

[22]  J. Seidman,et al.  A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation , 1990, Cell.

[23]  D. Stamatiou,et al.  Construction of a human cardiovascular cDNA microarray: portrait of the failing heart. , 2001, Biochemical and biophysical research communications.

[24]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[25]  D. Botstein,et al.  Genomic expression programs in the response of yeast cells to environmental changes. , 2000, Molecular biology of the cell.

[26]  C. Lee,et al.  Identification of differentially expressed genes in cardiac hypertrophy by analysis of expressed sequence tags. , 2000, Genomics.

[27]  J. Towbin,et al.  The role of cytoskeletal proteins in cardiomyopathies. , 1998, Current opinion in cell biology.

[28]  Christine E. Seidman,et al.  α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere , 1994, Cell.

[29]  M. Dalakas,et al.  Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. , 2000, The New England journal of medicine.

[30]  C. Ton,et al.  A cardiovascular EST repertoire: progress and promise for understanding cardiovascular disease. , 2000, Molecular medicine today.

[31]  K. Chien,et al.  Stress Pathways and Heart Failure , 1999, Cell.

[32]  J. Guerrero,et al.  Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  W. Hwang,et al.  Single pass sequencing of a unidirectional human fetal heart cDNA library to discover novel genes of the cardiovascular system. , 1994, Journal of molecular and cellular cardiology.

[34]  A. Marks,et al.  Cardiac intracellular calcium release channels: role in heart failure. , 2000, Circulation research.